<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00951067</url>
  </required_header>
  <id_info>
    <org_study_id>AQ-UE-LYMPHEDMA-PCD-RCT</org_study_id>
    <nct_id>NCT00951067</nct_id>
  </id_info>
  <brief_title>Pneumatic Compression Treatment For Upper Extremity Acquired Lymphedema</brief_title>
  <acronym>PCD-LYMPH</acronym>
  <official_title>Trial to Compare Pneumatic Compression Treatments for Upper Extremity Acquired Lymphedema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NormaTec Industries LP</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine how well different treatments for acquired
      lymphedema work.

      The study will compare 5 different non-invasive treatments for acquired lymphedema of the arm
      to see which treats lymphedema best.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will compare 5 non-invasive lymphedema treatments.

      Patients will be assigned to either:

      - A combination of arm exercises, arm elevation, and wearing of a compression garment every
      day

      OR

      - One of four possible pneumatic compression devices for just two hours every day.

      Pneumatic compression devices are made up of an inflatable sleeve connected to a small
      controller unit that is plugged into the wall. They feel like having your blood pressure
      taken.

      None of the treatments are experimental. None of the treatments are invasive. All the
      treatments are considered standard of care and are used in clinics throughout the United
      States. All of the treatments will be done at home.

      The trial will last for 7 and 1/2 months and will require follow-up visits to monitor
      progress.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Funding not available to continue with study.
  </why_stopped>
  <start_date>August 2009</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Arm Volume</measure>
    <time_frame>Arm volume will be measured at 2 weeks before treatment starts, day treatment begins, and then 1 month, 3 months, 6 months, and 7 months after treatment starts</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infection (cellulitis)</measure>
    <time_frame>Presence of infection will be recorded at 2 weeks before treatment starts, day treatment begins, and then 1 month, 3 months, 6 months, and 7 months after treatment starts</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Survey</measure>
    <time_frame>Survey will be given at 2 weeks before treatment starts, day treatment begins, and then 1 month, 3 months, 6 months, and 7 months after treatment starts</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Lymphedema</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Exercise, Elevation, and Garment Compression</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pneumatic Compression Device (B)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pneumatic Compression Device (C)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pneumatic Compression Device (D)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group E</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pneumatic Compression Device (E)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise, Elevation, and Compression Garment</intervention_name>
    <description>Patients will be asked to daily:
exercise
elevate arm
wear an arm compression garment</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>E0650 PCD with non-sequential waveform</intervention_name>
    <description>Use of an E0650 PCD with non-sequential waveform for two hours every day.</description>
    <arm_group_label>Group B</arm_group_label>
    <other_name>Brand: Huntleigh Flowtron Hydroven™ 3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>E0651 PCD with sequential, non-gradient waveform</intervention_name>
    <description>Use of an E0651 PCD with sequential, non-gradient waveform for two hours every day</description>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Brand: Petite Basic System (Model 701A) Lympha Press</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>E0652 PCD with sequential, gradient waveform</intervention_name>
    <description>Use of an E0652 PCD with sequential, gradient waveform for two hours every day.</description>
    <arm_group_label>Group D</arm_group_label>
    <other_name>Brand: Bio Compression Sequential Circulator 3008</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>E0652 PCD with peristaltic pulse waveform</intervention_name>
    <description>Use the E0652 PCD with peristaltic pulse waveform for two hours every day.</description>
    <arm_group_label>Group E</arm_group_label>
    <other_name>NormaTec brand</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with acquired lymphedema of the arm.

        Exclusion Criteria:

          -  Refusal of consent

          -  Unlikely compliance with the research protocol

          -  Acute upper extremity DVT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arin K Greene, MD, MMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children’s Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Boston at Waltham</name>
      <address>
        <city>Waltham</city>
        <state>Massachusetts</state>
        <zip>02453</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2009</study_first_submitted>
  <study_first_submitted_qc>August 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2009</study_first_posted>
  <last_update_submitted>January 30, 2014</last_update_submitted>
  <last_update_submitted_qc>January 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lymphedema</keyword>
  <keyword>Breast Cancer</keyword>
  <keyword>Upper Extremity</keyword>
  <keyword>Arm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

